FLGT
Fulgent Genetics Inc
NASDAQ: FLGT · HEALTHCARE · DIAGNOSTICS & RESEARCH
$19.64
+0.05% today
Updated 2026-07-29
Market cap
$558.64M
P/E ratio
—
P/S ratio
1.74x
EPS (TTM)
$-2.37
Dividend yield
—
52W range
$13 – $31
Volume
0.4M
Fulgent Genetics Inc (FLGT) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$19.64
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$49.90
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.0B | $0.6B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: -5.21% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -23.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.